Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi) profile picture

Nephrology consultant, #FOAMed, photography lover, and a traveller

Vijayawada, India
Joined June 2010
Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)Photo by Varun Kumar B MD, DM, FISN, FASN (@varunkumarbandi)
NC-031 | Secondary hyperparathyroidism πŸ¦‹πŸ¦΄ 🫘 Not on dialysis: fix the drivers (phosphate, low Ca, vit D deficiency). Calcitriol only if severe & progressive. πŸ₯ On dialysis: PTH ~2–9Γ— ULN. Calcimimetic, calcitriol, or both. ...1/4 #VKBneph #NephTwitter
1
3
8
533
NC-031.2 | πŸ“… Monitoring PTH: baseline in G3; every 6–12 months in G4; every 3–6 months in G5/5D Cinacalcet: Ca within 1 week of a dose change, PTH at 1–4 weeks 🧠 Etelcalcetide is given IV after each HD session: adherence solved
1
29
NC-031.3 | πŸ”ͺ Parathyroidectomy PTH refractory to medical therapy, hypercalcaemia, calciphylaxis or bone disease with high PTH. ⚠️ Watch for hungry bone syndrome after surgery. 🫘 Untreated HPT can persist as tertiary HPT after transplant. @goKDIGO
18
NC-030 | Phosphate control in CKD πŸ₯«πŸ¦΄ 1️⃣ Cut additives: processed food & colas πŸ₯€ (~90% absorbed) 2️⃣ Plant protein is fine πŸ₯¦ (phytate β†’ poorly absorbed) 3️⃣ Binders with meals; limit calcium-based 4️⃣ On dialysis: time on dialysis ⏱️ matters ....1/4 #VKBneph #NephTwitter
1
2
6
252
NC-030.2 | 🧠 Pill-burden trivia HD patients take a median of ~19 pills a day, and phosphate binders make up about half (Chiu, CJASN 2009). Higher pill burden β†’ lower adherence and quality of life.
1
1
22
NC-030.3 | πŸ“… KDIGO lab schedule (Ca & phosphate) G3 β†’ every 6–12 months G4 β†’ every 3–6 months G5 / dialysis β†’ every 1–3 months 🎯 Lower high phosphate toward normal; restrict calcium-based binders @goKDIGO
14
NC-029 | CKD-MBD: the cascade 🦴🫘 As GFR falls: 1️⃣ FGF23 rises first (G2–3) 2️⃣ Calcitriol falls 3️⃣ PTH rises 4️⃣ Phosphate rises late (G4–5) ⚠️ Normal phosphate β‰  normal mineral metabolism #VKBneph #NephTwitter
1
14
48
2,247
NC-029.2 | 🧠 Name trivia 🧡 Klotho (found 1997) is named after the Greek Fate who spins the thread of life. Mice lacking it age prematurely. 🧬 FGF23 was discovered in 2000 through autosomal dominant hypophosphataemic rickets.
1
61
NC-029.3 | πŸ“‹ CKD-MBD is three things πŸ§ͺ Abnormal labs (Ca, phosphate, PTH, vitamin D) 🦴 Bone disease (turnover, mineralisation, volume) πŸ«€ Vascular & soft-tissue calcification πŸ“š KDIGO 2017 CKD-MBD update @goKDIGO
1
45
NC-028 | Week recap: CKD anaemia in 5 steps 🩸🫘 1️⃣ Confirm & exclude other causes 2️⃣ Replete iron first 3️⃣ ESA if Hb still <9–10; aim ≀11.5 4️⃣ Poor response? Hunt inflammation πŸ”₯ 5️⃣ HIF-PH inhibitor: oral option on dialysis Save πŸ”– #VKBneph #NephTwitter
1
3
9
526
NC-028.1 | 🧠 One line per trial CHOIR Β· CREATE Β· TREAT β†’ don't normalise Hb PIVOTAL β†’ proactive IV iron on HD is safe DRIVE β†’ high ferritin β‰  no iron ASCEND-D β†’ HIF-PHI β‰ˆ ESA on dialysis
1
65
NC-028.2 | πŸ—‚οΈ Anaemia week index NC-022 Work-up NC-023 Oral vs IV iron NC-024 ESA targets NC-025 HIF-PH inhibitors NC-026 PIVOTAL NC-027 Hyporesponse case ⏭️ Next week: CKD-mineral and bone disorder 🦴
51
NC-027 | Saturday case 🧩🩸 πŸ‘© 55F on haemodialysis via a tunnelled catheter πŸ“‰ Hb 8.7 despite doubling her ESA dose πŸ§ͺ Ferritin 850 Β· TSAT 14% Β· CRP 48 🌑️ Low-grade fevers after sessions Best next step? πŸ‘‡ ...1/4 #VKBneph #NephTwitter
1
130
NC-027.2 | πŸŽ“ The academic twist DRIVE (JASN 2007): in HD patients with ferritin 500–1,200 and TSAT ≀25%, IV ferric gluconate raised Hb. So high ferritin alone doesn't forbid iron. But not during active infection 🦠🚫
1
45
NC-027.3 | πŸ“‹ ESA hyporesponse checklist 🦠 Infection / inflammation 🩸 Iron deficiency, blood loss 🦴 Severe hyperparathyroidism ⏱️ Inadequate dialysis πŸ§ͺ B12/folate, haemolysis, aluminium πŸ’Š ACEi 🧬 Anti-EPO pure red cell aplasia
22
NC-026 | Trial Friday βš–οΈ PIVOTAL πŸ’‰ Proactive iron sucrose 400 mg/month vs reactive low-dose πŸ‘₯ 2,141 new to haemodialysis ⏱️ Median 2.1 years πŸ«€ Death, MI, stroke or HF admission: HR 0.85 (0.73–1.00) πŸ’‰ ESA dose ↓19% 🦠 No ↑ infections ....1/4 #VKBneph
1
3
186
NC-026.2 | πŸ” Inside the result πŸ«€ Heart failure hospitalisation fell the most (HR 0.66) 🩸 Fewer transfusions 🦠 Infection rates no different, easing a long-held fear about IV iron
1
33
NC-026.3 | πŸ“Œ Practice change Higher ferritin ceilings on HD became acceptable, and proactive dosing became standard in many units. 🧠 The largest RCT of IV iron dosing in dialysis. πŸ“š Macdougall IC et al. NEJM 2019;380:447–58 @NephJC
13